Abstract:T cells play a critical role in allograft rejection. T-cell activation requires antigen recognition by the T-cell receptor (TCR)/CD3 complex and costimulation of accessory receptors. Non-FcR-binding anti-CD3ε antibodies (Abs) produce immunosuppression without the toxicity associated with Fc-dependent activation (1). Non-FcR-binding anti-CD3ε Abs may induce T-cell anergy, skew the T-cell repertoire toward the Th2 phenotype, modulate the TCR, and block antigen recognition (1). We have found that a critical mechanism of immunosuppression by non-FcR-binding anti-CD3ε Abs is the induction of apoptosis in antigen-activated T cells (2). Among the costimulatory receptors on T cells, CD28 has a pivotal role in the initiation and maintenance of T-cell responses. In various transplant models, inhibition of CD28:B7 interactions by CTLA4-Ig resulted in immunosuppression (3). However, treatment with anti-CD28 Abs was more effective than CTLA4-Ig in the prevention of graft-versus-host disease in mice (4). Therefore, selective targeting of CD28 may be a better approach to achieve transplantation tolerance than blocking B7 molecules, the ligands for both CD28 and CTLA4, as CTLA4 is inhibitory for T-cell activation. Here we tested the hypothesis that combined treatment with non-FcR-binding anti-CD3ε plus anti-CD28 Abs leads to transplantation tolerance by affecting independent and complementary pathways of T cell activation. The experiments were performed in the context of a strong allogeneic MHC stimulation by transplanting skin grafts from BALB/c (H2d) onto C57BL/6 (H2b) mice. Recipients were treated with control Ab, anti-CD28 alone, non-FcR-binding anti-CD3ε alone, or anti-CD3ε plus anti-CD28. As shown in Figure 1A, treatment with anti-CD3 significantly prolonged graft survival compared to control or anti-CD28 treatment (P <0.0001, P <0.0001), whereas anti-CD28 by itself was modestly effective (P =0.002). The combination of anti-CD3ε plus anti-CD28 Abs was significantly more effective than either Ab alone (P =0.002, and P <0.0001), but transplantation tolerance did not develop. We suspected that failure to achieve graft tolerance could result from non-tolerant T cells developing from the thymus after stopping treatment. These T cells could recognize alloantigens and reject the skin graft. To test this hypothesis, we utilized thymectomized C57BL/6 mice as recipients. Treatment with anti-CD3ε plus anti-CD28 Abs significantly prolonged graft survival compared to control Ab (Fig. 1B), but the magnitude of the effect was not significantly different in normal or thymectomized recipients (P =0.5). Figure 1: Prolongation of murine skin allograft survival. Normal (A) or thymectomized (B) C57BL/6 mice were transplanted with full-thickness skin grafts from BALB/c donors. Recipients were intraperitoneally injected with the reagents indicated once every other day for a total of eight doses. The dose of anti-CD3ε and anti-CD28 Abs were 80 and 100 μg/mouse, respectively. The control Ab used was normal hamster IgG.We conclude that anti-CD3 and anti-CD28 Abs have additive immunosuppressive effects, but their combination does not induce tolerance to skin transplants. The failure of inducing transplantation tolerance with this treatment is not caused by the emergence of non-tolerant T cells from the host thymus, but may result from incomplete depletion of alloreactive T cells, lack of inducing T-cell unresponsiveness, and/or lack of generating regulatory T cells. Xue-Zhong Yu1 Yoshio Nitta2,3 Sasha J. Bidwell1 Claudio Anasetti1,4

The relation between prolonged survival of skin allograft by chuan-ke-zhi and CD4~+CD25~+ regulatory Tcells

Infusion of Donor Hepatic Non-Parenchymal Cells Prolongs Survival of Skin Allografts in Mice:Role of Microchimerism and IL-4

Prolonged Survival of Skin Graft by Dendritic Cells Derived Donor-Specific Ilt3 Lentivirus-Transduced Human Cd34(+) Cells in Hu-Nod/Scid Mice

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

IL-25 Promotes the Function of CD4+CD25+ T Regulatory Cells and Prolongs Skin-Graft Survival in Murine Models.

[Effects of Allogeneic Hepatic Nonparenchymal Cell on the Survival of Grafted Skin in Mice].

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Effects of Nrp1~+ T cells on the regulation of lymphocyte proliferation and survival time of allograft

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model

Prolongation of Skin Allograft Survival in Mice by Syngenic Hematopoietic Stem Cell Transplantation

Development of the Model of Long Term Donor Specific Skin Allograft Survival Induced by Pretransplant Infusion of Donor Liver Nonparenchymal Cells

Immunoregulation Effects of CD4+ CD25+ T Cells in Mice Heart Allograft Transplantation

[Influence of Donor Treg Cells on GVHD and GVL Effects after Allogeneic Bone Marrow Transplantation in Mice].

IL-25 promotes the function of CD4+CD25+ T regulatory cells and prolongs skin-graft survival in murine models (IRC5P.620)

Synergistic Effect of CsA and DBMC on Heterotopic Rat Cardiac Allograft Survival

[Experimental Study of Tripterygium Hypoglaucum (level) Hutch on Preventing Acute Graft-Versus-host Disease in Bone Marrow Transplantation Mice].

Bone Marrow Infusion in Combined with Costimulatory Signal System Blockade Prolonged the Survival Time of Grafted Skin in Rats

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.

MD-1 expression and its effects on skin allograft under immunosuppressive condition in mice

Mechanism of Donor Antigen-Specific CD4+CD25+regulatory T Cells on Prolonging Islet Grafts Survival

ADDITIVE EFFECTS OF ANTI-CD3 AND ANTI-CD28 ON PROLONGATION OF ALLOGENEIC SKINGRAFT SURVIVAL